Published in Environ Health Perspect on December 01, 1976
Lead and hyperactivity. Lancet (1972) 2.42
Behavioral toxicology: a developing discipline. Fed Proc (1975) 1.32
Assessing the impact of low level chemicals on development: behavioral and latent effects. Fed Proc (1975) 1.19
Vulnerability of children to lead exposure and toxicity (first of two parts). N Engl J Med (1973) 1.13
Critical periods for behavioral anomalies in mice. Environ Health Perspect (1976) 1.06
Growth, behavior, and brain catecholamines in lead-exposed neonatal rats: a reappraisal. Science (1975) 1.05
Human cerebral blood flow and oxygen consumption as related to aging. Res Publ Assoc Res Nerv Ment Dis (1956) 1.02
The susceptibility of the fetus and child to chemical pollutants. Behavioral implications of prenatal and early postnatal exposure to chemical pollutants. Pediatrics (1974) 0.95
Hyperactivity: a lead-induced behavior disorder. Environ Health Perspect (1974) 0.92
Behavioral testing as a method for assessing risk. Environ Health Perspect (1976) 0.84
Estimating separately personal exposure to ambient and nonambient particulate matter for epidemiology and risk assessment: why and how. J Air Waste Manag Assoc (2000) 3.58
Prenatal and postnatal effects of low-level lead exposure: integrated summary of a report to the U.S. Congress on childhood lead poisoning. Environ Res (1989) 1.85
Contributions of the caregiving environment to increased lead burden of children. Am J Ment Defic (1980) 1.23
Hepatic undifferentiated (embryonal) sarcoma arising in a mesenchymal hamartoma. Am J Surg Pathol (1997) 1.17
The comparative developmental neurotoxicity of lead in humans and animals. Neurotoxicol Teratol (1990) 1.01
Temporal parameters of d-amphetamine as a discriminative stimulus in the rat. Psychopharmacologia (1976) 1.00
Chronic low-level lead toxicity in the rat. III. An integrated assessment of long-term toxicity with special reference to the kidney. Toxicol Appl Pharmacol (1980) 0.95
Brainstem catecholamine neurons are target sites for sex steroid hormones. Science (1980) 0.93
Alteration of avoidance and ingestive behavior after destruction of central catecholamine pathways with 6-hydroxydopamine. Pharmacol Biochem Behav (1975) 0.92
Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine. J Pharmacol Exp Ther (1973) 0.91
Adenomatoid tumor of the adrenal gland: a report of four new cases and a review of the literature. Mod Pathol (1996) 0.90
Chronic low-level lead toxicity in the rat. II. Effects on postnatal physical and behavioral development. Toxicol Appl Pharmacol (1980) 0.89
Alterations in consummatory behavior following intracisternal injection of 6-hydroxydopamine. Pharmacol Biochem Behav (1974) 0.88
Selective potentiation of locomotor effects of amphetamine by midbrain raphé lesions. Physiol Behav (1972) 0.88
Chronic low-level lead toxicity in the rat. I. Maternal toxicity and perinatal effects. Toxicol Appl Pharmacol (1980) 0.87
Summary of discussion sessions: symposium on lead-blood pressure relationships. Environ Health Perspect (1988) 0.86
Growth, endocrinological and behavioral deficits after monosodium L-glutamate in the neonatal rat: possible involvement of arcuate dopamine neuron damage. Psychoneuroendocrinology (1977) 0.85
Current issues in human lead exposure and regulation of lead. Neurotoxicology (1994) 0.84
(3-H)-dihydrotestosterone in catecholamine neurons of rat brain stem: combined localization by autoradiography and formaldehyde-induced fluorescence. J Comp Neurol (1981) 0.81
Spindle cell squamous carcinoma of the esophagus: analysis of ploidy and tumor proliferative activity in a series of 13 cases. Hum Pathol (1998) 0.80
Lead poisoning and reproduction: effects on pituitary and serum gonadotropins in neonatal rats. Environ Res (1979) 0.78
Biochemical and behavioural alterations following 5,6-dihydroxytryptamine administration into brain. Neuropharmacology (1974) 0.78
Enhanced behavioral depressant effects of reserpine and -methyltyrosine after 6-hydroxydopamine treatment. Psychopharmacologia (1972) 0.78
Chronic neonatal organotin exposure alters radial-arm maze performance in adult rats. Neurobehav Toxicol Teratol (1982) 0.77
Hyperdipsia after serotonin-depleting midbrain lesions. Nat New Biol (1972) 0.77
Functional dissociation within hippocampus. Brain Res (1968) 0.76
Muricide after serotonin depleting lesions of midbrain raphé nuclei. Pharmacol Biochem Behav (1974) 0.76
Effects of lead on temporally-spaced responding in rats. Drug Chem Toxicol (1978) 0.76
Effects of neonatal lead exposure on memory in rats. Neurobehav Toxicol Teratol (1981) 0.76
Combined autoradiography and formaldehyde-induced fluorescence methods for localization of radioactively labeled substances in relation to monoamine neurons. J Histochem Cytochem (1981) 0.75
3H estradiol in catecholamine neurons of rat brain stem: combined localization by autoradiography and formaldehyde-induced fluorescence. J Comp Neurol (1977) 0.75
Effects of intracisternal 6-hydroxydopamine treatment on acquisition and performance of rats in a double T-maze. J Comp Physiol Psychol (1974) 0.75
Stimulus properties of thyrotropin-releasing hormone. Psychopharmacology (Berl) (1978) 0.75
The changing risk assessments for crystalline silica. J Expo Anal Environ Epidemiol (1997) 0.75
The brain: an endocrine organ and hormone target. Science (1974) 0.75
Electrical self-stimulation without lead wires. J Exp Anal Behav (1968) 0.75
Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion. Physiol Behav (1973) 0.75
Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments. Psychopharmacologia (1973) 0.75